Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Israeli Stocks: Teva, Africa Israel Residences, ICL, Redhill

Sept. 20 (Bloomberg) -- Israel’s TA-25 Index advanced the most in almost two weeks, gaining 3.3 percent to 1,067.99 at the 4:30 p.m. close in Tel Aviv. Investors traded about 1.5 billion shekels ($407 million) of shares and convertible securities today, according to Tel Aviv Stock Exchange data.

The following stocks rose or fell today. Symbols are in parentheses.

Africa Israel Residences Ltd. (AFRE IT) soared 20 percent, the biggest gain since November 2008, to 34.87 shekels. The property developer said its board approved spending as much as 40 million shekels to buy back shares.

Israel Chemicals Ltd. (ICL IT) increased 2.4 percent to 46.30 shekels, the highest level since Sept. 4. The company that extracts minerals from the Dead Sea to make fertilizer was initiated with a “buy” recommendation and 60 shekel share-price estimate at Excellence Nessuah Brokerage Services.

Redhill Biopharma Ltd. (RDHL IT) rose the highest since Sept. 1, advancing 3.9 percent to 2.299 shekels. The biopharmaceutical company said yesterday it agreed to buy the rights to a diagnostic test to help identify a bacteria connected to Crohn’s disease.

Teva Pharmaceutical Industries Ltd. (TEVA IT) declined to the lowest since Aug. 15, dropping 1.4 percent to 138.30 shekels. Clal Finance Brokerage Ltd. reduced the shares of the world’s largest maker of generic drugs to “market perform” and withdrew its price estimate.

To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at ssolomon22@bloomberg.net

To contact the editor responsible for this story: Claudia Maedler at cmaedler@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.